Stay updated on OMS721 in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.

Latest updates to the OMS721 in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the OMS721 IgA nephropathy study is available, with study details, results, and supporting documents. It reports that the trial was terminated because it did not meet its prespecified primary endpoint.SummaryDifference100%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedA sitewide NIH banner was added announcing a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advanced from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now displays a 403 Forbidden page, replacing the content and links with an access-denied screen.SummaryDifference18%

Stay in the know with updates to OMS721 in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.